KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$0.0536
+0 (+0%)
At Close: Apr 15, 2020
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
May 23, 2019 $0.0570 $0.0790 $0.0570 $0.0790 353
May 22, 2019 $0.0570 $0.0700 $0.0570 $0.0700 318
May 21, 2019 $0.0789 $0.0790 $0.0571 $0.0790 1 758
May 20, 2019 $0.0570 $0.0570 $0.0570 $0.0570 3 563
May 17, 2019 $0.0840 $0.0840 $0.0570 $0.0570 632
May 16, 2019 $0.0680 $0.0680 $0.0586 $0.0586 1 730
May 15, 2019 $0.0570 $0.0690 $0.0570 $0.0570 1 180
May 14, 2019 $0.0570 $0.0570 $0.0570 $0.0570 1 235
May 13, 2019 $0.0570 $0.0700 $0.0570 $0.0700 1 473
May 10, 2019 $0.0635 $0.0700 $0.0600 $0.0700 1 925
May 09, 2019 $0.0570 $0.0700 $0.0570 $0.0700 2 477
May 08, 2019 $0.0416 $0.0700 $0.0416 $0.0700 202
May 07, 2019 $0.0700 $0.0700 $0.0700 $0.0700 331
May 06, 2019 $0.0650 $0.0700 $0.0650 $0.0700 725
May 03, 2019 $0.0551 $0.0800 $0.0551 $0.0700 6 940
May 02, 2019 $0.0620 $0.0800 $0.0600 $0.0800 204 951
May 01, 2019 $0.0800 $0.0800 $0.0620 $0.0800 49 289
Apr 30, 2019 $0.0800 $0.0800 $0.0621 $0.0800 2 525
Apr 29, 2019 $0.0620 $0.0800 $0.0620 $0.0657 4 386
Apr 26, 2019 $0.0710 $0.0790 $0.0620 $0.0790 36 089
Apr 25, 2019 $0.0620 $0.0800 $0.0620 $0.0800 9 344
Apr 24, 2019 $0.0660 $0.0800 $0.0640 $0.0800 13 556
Apr 23, 2019 $0.0660 $0.0800 $0.0640 $0.0800 10 538
Apr 22, 2019 $0.0800 $0.0800 $0.0640 $0.0800 853
Apr 18, 2019 $0.0720 $0.0800 $0.0640 $0.0800 13 296
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT